DAPK1 (GeneID: 1612) | Homo sapiens
Description: death associated protein kinase 1 [Source:HGNC Symbol;Acc:HGNC:2674]
Synonyms: DAPK, ROCO3
Other ID(s): HGNC:2674, ENSG00000196730
Protein Accession Numbers: ENST00000469640, NP_001275659, ENST00000489291, ENST00000408954, NP_004929, NP_001275658, ENST00000472284, ENST00000358077, NP_001275660, ENST00000491893
Statistics: gnomAD(1166) COSMIC(906) PTM(36)
Post translational modifications (PTM) by Type
6%72%22%10010090908080707060605050404030302020101000
Acetylation
Phosphorylation
Ubiquitination
Download SVG
Download PNG
Download CSV

∙ Please click the name of species for the protein accession number used in the alignment.
∙ A p letter used as a pointer to positions of post translational modifications in human.
∙ Protein domains illustrated above belong to Homo sapiens (Human).
∙ ClinVar stacked bar chart represents whole protein isoforms of the gene. Please, check the other protein isoforms of the gene below.
∙ If more than one transcripts below are active (with blue background color), it means all the active transcripts have the same sequence.
ENST00000358077 ENST00000408954 ENST00000469640 ENST00000472284 ENST00000489291 ENST00000491893 NP_001275658 NP_001275659 NP_001275660 NP_004929


healinggnomAD
61%1%34%10010090908080707060605050404030302020101000
Frameshift Variant
Inframe Deletion
Inframe Insertion
Missense Variant
Splice Region Variant
Stop Gained
Stop Lost
Synonymous Variant
Download SVG
Download PNG
Download CSV

placePost-translational Modifications (PTMs)
6%72%22%10010090908080707060605050404030302020101000
Acetylation
Phosphorylation
Ubiquitination
Download SVG
Download PNG
Download CSV

blur_onCatalogue of Somatic Mutations in Cancer (COSMIC)
12%26%2%58%10010090908080707060605050404030302020101000
Deletion - Frameshift
Deletion - In Frame
Insertion - Frameshift
Substitution - Coding Silent
Substitution - Missense
Substitution - Nonsense
Unknown
Download SVG
Download PNG
Download CSV

format_align_centerProtein Domains (PFAM)
Pfam Domain filter_list Domain Name filter_list Description filter_list Positions filter_list Clan filter_list Clan Name filter_list Organism filter_list
NO RESULT FOUND
PF00531 Death Death domain 1145-1228 CL0041 Death Caenorhabditis elegans
PF12796 Ank_2 Ankyrin repeats (3 copies) 352-427 CL0465 Ank Caenorhabditis elegans
PF12796 Ank_2 Ankyrin repeats (3 copies) 416-493 CL0465 Ank Caenorhabditis elegans
PF12796 Ank_2 Ankyrin repeats (3 copies) 194-295 CL0465 Ank Caenorhabditis elegans
PF12796 Ank_2 Ankyrin repeats (3 copies) 280-361 CL0465 Ank Caenorhabditis elegans
PF00069 Pkinase Protein kinase domain 1-128 CL0016 PKinase Caenorhabditis elegans

view_listList of the diseases from DisGeNET
Disease Name filter_list Disease Category filter_list DSI* filter_list DPI** filter_list
Adenocarcinoma Neoplasms ; 0.513 0.655
Brain Neoplasms Neoplasms ; Nervous System Diseases ; 0.513 0.655
Non-Small Cell Lung Carcinoma Neoplasms ; Respiratory Tract Diseases ; 0.513 0.655
Renal Cell Carcinoma Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; 0.513 0.655
Carcinoma, Transitional Cell Neoplasms ; 0.513 0.655
Conjunctival Diseases Eye Diseases ; 0.513 0.655
Adenoid Cystic Carcinoma Neoplasms ; 0.513 0.655
Leukemia, Myelocytic, Acute Neoplasms ; 0.513 0.655
Lung Neoplasms Neoplasms ; Respiratory Tract Diseases ; 0.513 0.655
Acute Myeloid Leukemia, M1 Neoplasms ; 0.513 0.655
Neoplasm Metastasis Neoplasms ; Pathological Conditions, Signs and Symptoms ; 0.513 0.655
Peripheral Neuropathy Nervous System Diseases ; 0.513 0.655
Respiratory Tract Diseases Respiratory Tract Diseases ; 0.513 0.655
Salivary Gland Neoplasms Neoplasms ; Stomatognathic Diseases ; 0.513 0.655
Neoplasms, Second Primary Neoplasms ; 0.513 0.655
Neoplasms, Therapy-Associated Neoplasms ; 0.513 0.655
Juvenile-Onset Still Disease Musculoskeletal Diseases ; Skin and Connective Tissue Diseases ; Immune System Diseases ; 0.513 0.655
Malignant neoplasm of brain Neoplasms ; Nervous System Diseases ; 0.513 0.655
Adenocarcinoma, Basal Cell Neoplasms ; 0.513 0.655
Adenocarcinoma, Oxyphilic Neoplasms ; 0.513 0.655
Carcinoma, Cribriform Neoplasms ; 0.513 0.655
Carcinoma, Granular Cell Neoplasms ; 0.513 0.655
Adenocarcinoma, Tubular Neoplasms ; 0.513 0.655
Malignant neoplasm of salivary gland Neoplasms ; Stomatognathic Diseases ; 0.513 0.655
Malignant neoplasm of lung Neoplasms ; Respiratory Tract Diseases ; 0.513 0.655
Conventional (Clear Cell) Renal Cell Carcinoma Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; 0.513 0.655
Benign neoplasm of brain, unspecified Neoplasms ; Nervous System Diseases ; 0.513 0.655
Brain Tumor, Primary Neoplasms ; Nervous System Diseases ; 0.513 0.655
Recurrent Brain Neoplasm Neoplasms ; Nervous System Diseases ; 0.513 0.655
Primary malignant neoplasm of brain Neoplasms ; Nervous System Diseases ; 0.513 0.655
Treatment related secondary malignancy Neoplasms ; 0.513 0.655
Chromophobe Renal Cell Carcinoma Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; 0.513 0.655
Sarcomatoid Renal Cell Carcinoma Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; 0.513 0.655
Collecting Duct Carcinoma of the Kidney Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; 0.513 0.655
Papillary Renal Cell Carcinoma Neoplasms ; Male Urogenital Diseases ; Female Urogenital Diseases and Pregnancy Complications ; 0.513 0.655
Neoplasms, Intracranial Neoplasms ; Nervous System Diseases ; 0.513 0.655
Acute Myeloid Leukemia (AML-M2) Neoplasms ; 0.513 0.655
Hematopoetic Myelodysplasia Hemic and Lymphatic Diseases ; 0.513 0.655
MYELODYSPLASTIC SYNDROME Hemic and Lymphatic Diseases ; 0.513 0.655
Juvenile arthritis Musculoskeletal Diseases ; Skin and Connective Tissue Diseases ; Immune System Diseases ; 0.513 0.655
Juvenile psoriatic arthritis Musculoskeletal Diseases ; Skin and Connective Tissue Diseases ; Immune System Diseases ; 0.513 0.655
NO RESULT FOUND
feedback

Send a feedback about the results.